Gladstone NOW: The Campaign Join Us on the Journey✕
Several recent science studies have claimed that the gut microbiome—the diverse array of bacteria that live in the stomach and intestines—may be to blame for obesity. But Katherine Pollard, PhD, a senior investigator at the Gladstone Institutes, says it is not that simple.
Dr. Pollard will be presenting at the Obesity and Microbiome symposium at the AAAS Annual Meeting in San Jose, CA on Friday, February 13, 2015 at 3:00 PM PT.
Using powerful computational tools, Dr. Pollard and her team have reanalyzed several previous studies and revealed that there is no significant relationship between body mass index (BMI) and the types of microbes in one’s gut. In fact, her lab found that there was greater variability in gut bacteria between the different studies than between the lean and obese individuals within each study.
Instead, Dr. Pollard thinks that it is the genetic make-up of the different strains of bacteria that is most important. This is because the DNA in bacteria can vary wildly. For example, while the genomes of two humans may only differ by 0.1%, two strains of the same bacteria can vary by to 30%—similar to the variation between human and mice genomes. What’s more, the differences in the bacterial genomes are often essential pieces that are involved in metabolism or the processing of sugar and fat.
Besides reflecting key functional changes in bacterial genomes, losses and gains of genes also affect genome size. When microbiomes are studied using metagenomics—sequencing their total DNA—differences in bacterial genome size can bias the estimation of the proportion of each gene in the sample. By developing a computational shortcut to rapidly estimate genome size using statistical modeling, Dr. Pollard’s team has been able to improve the accuracy of microbiome studies.
“It’s not enough to say what type of bacterial species are present, because that doesn’t tell you what they’re doing,” explains Dr. Pollard. “Since two strains of the same species can have such different genomes, you really need to know what genes are there and what role they play in order to link someone’s gut microbiota to BMI or disease.”
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
A new study in Nature Genetics expands our understanding of immune regulation and autoimmunity—with findings that could also be used in the development of cancer immunotherapies.
News Release Autoimmune Diseases Cancer Genomic Immunology Parker Institute for Cancer Immunotherapy Marson Lab Pollard Lab Ye Lab AI CRISPR/Gene EditingA team of researchers from Gladstone Institutes and UC San Francisco combined high-throughput experiments and machine learning to analyze more than 100,000 sequences in human brain cells.
News Release Research (Publication) Data Science and Biotechnology Pollard Lab AI Big Data Developmental Biology Disease Models Genomics Human GeneticsA search for the brightest minds in cancer and AI led Hope and Sanjit Biswas to give in their own backyard.
Philanthropy Donor Stories Cancer Biswas Center for Transformative Computational Cancer Biology Data Science and Biotechnology Pollard Lab AI Big Data